Core Laboratories Inc. /DE/ Annual Income Tax Expense (Benefit) in USD from 2021 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Core Laboratories Inc. /DE/ quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2021 to 2023.
  • Core Laboratories Inc. /DE/ Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $4.69M, a 104% increase year-over-year.
  • Core Laboratories Inc. /DE/ Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was $10.1M.
  • Core Laboratories Inc. /DE/ annual Income Tax Expense (Benefit) for 2023 was -$4.19M, a 141% decline from 2022.
  • Core Laboratories Inc. /DE/ annual Income Tax Expense (Benefit) for 2022 was $10.3M, a 35.2% decline from 2021.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$4.19M -$14.5M -141% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-15
2022 $10.3M -$5.6M -35.2% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-15
2021 $15.9M Jan 1, 2021 Dec 31, 2021 10-K 2024-02-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.